Patent rejection: 'Novartis remains committed'


The managing director, of the Swiss drugmaker Navartis says the company is disappointed to have had its patent rejected by India's Supreme Court.

Speaking to the BBC, Ranjit Shahani said Navartis "remains committed to patients."

The Swiss drugmaker was denied a patent by Indian authorities on the grounds that the new version was only slightly different from the old.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.